Category: Antibodies

Filter By
Categories: ELISA Antibody Pairs Categories: Intracellular Functional Antibodies Clear all
Tremelimumab Tremelimumab

Tremelimumab

Reference: HY-P9918
€0.00 (tax incl.)
Tremelimumab (Ticilimumab) is a fully humanized monoclonal antibody specific for cytotoxic T-lymphocyte antigen-4 (CTLA-4) and can be used for metastatic melanoma research.
Adalimumab (anti-TNF-α) Adalimumab (anti-TNF-α)

Adalimumab (anti-TNF-α)

Reference: HY-P9908A
€0.00 (tax incl.)
Adalimumab (anti-TNF-α) is a human monoclonal IgG1 antibody targeting tumour necrosis factor α (TNF-α).
Labetuzumab Labetuzumab

Labetuzumab

Reference: HY-P99160
€0.00 (tax incl.)
Labetuzumab is a humanised anti-carcinoembryonic antigen (CEA) monoclonal antibody that inhibits tumour growth and sensitises human medullary thyroid cancer xenografts to Dacarbazine chemotherapy.
Iscalimab Iscalimab

Iscalimab

Reference: HY-P99670
€0.00 (tax incl.)
Iscalimab (CFZ-533) is a non-depleting IGg1 monoclonal antibody targeting CD40 (KD: 0.3 nM). Iscalimab can be used for research of Graves' hyperthyroidism and autoimmune diseases.
Lerdelimumab Lerdelimumab

Lerdelimumab

Reference: HY-P99695
€0.00 (tax incl.)
Lerdelimumab (CAT-152) is an IgG4 human anti-TGF-β2 recombinant monoclonal antibody. Lerdelimumab can be used as an anti-scarring agent for glaucoma research.
Ziltivekimab Ziltivekimab

Ziltivekimab

Reference: HY-P99505
€0.00 (tax incl.)
Ziltivekimab (COR-001) is a human anti-IL-6 monoclonal antibody that is effective in reducing serum CRP. Ziltivekimab has anti-inflammatory activity and may be used in studies of chronic systemic inflammation and...
Pivekimab Pivekimab

Pivekimab

Reference: HY-P99234
€0.00 (tax incl.)
Pivekimab is a human IgG1 monoclonal antibody targeting interleukin 3 (IL-3) and CD123. Pivekimab can be used in the study of blastocytic plasmacytoid dendritic cell tumor (BPDCN).
Grisnilimab setaritox Grisnilimab setaritox

Grisnilimab setaritox

Reference: HY-P99651
€0.00 (tax incl.)
Grisnilimab setaritox (WT1-RTA), is an antihuman T cell antibody (anti-CD7) conjugating with ricin A chain (RTA). RTA is a 30-kDa peptide capable of rapidly in activating ribosomal 60S subunits. Grisnilimab setaritox...
Gatralimab Gatralimab

Gatralimab

Reference: HY-P99635
€0.00 (tax incl.)
Gatralimab (GZ-402668) is an IgG1 anti-CD52 monoclonal antibody.
Oleclumab Oleclumab

Oleclumab

Reference: HY-P99039
€0.00 (tax incl.)
Oleclumab (MEDI9447) is a human IgG1λ anti-CD73 monoclonal antibody that inhibits CD73 function. Oleclumab has an anti-tumor activity.
Parsatuzumab Parsatuzumab

Parsatuzumab

Reference: HY-P99215
€0.00 (tax incl.)
Parsatuzumab (Anti-EGFL7; RG 7414) is a humanized monoclonal antibody, acts as an immunomodulator and binds to EGFL7. Parsatuzumab selectively blocks the interaction between EGFL7 and endothelial cells, potentially...
Nimotuzumab Nimotuzumab

Nimotuzumab

Reference: HY-P9968
€0.00 (tax incl.)
Nimotuzumab is a humanized IgG1 monoclonal antibody targeting EGFR with a KD of 0.21 nM. Nimotuzumab is directed against the extracellular domain of the EGFR blocking the binding to its ligands. Nimotuzumab, a strong...
Domagrozumab Domagrozumab

Domagrozumab

Reference: HY-P99857
€0.00 (tax incl.)
Domagrozumab is an anti-myostatin humanized monoclonal antibody with a KD value of 2.6 pM for human myostatin. Domagrozumab induces muscle anabolic activity. Domagrozumab can be used in research of duchenne muscular...
Zolbetuximab Zolbetuximab

Zolbetuximab

Reference: HY-P99058
€0.00 (tax incl.)
Zolbetuximab (IMAB362) is a monoclonal antibody targeting Claudin-18.2. Zolbetuximab mediates specific killing of Claudin-18.2-positive cells through immune effector mechanisms. Zolbetuximab can be used for the...
Human IgG4 kappa, Isotype Control Human IgG4 kappa, Isotype Control

Human IgG4 kappa, Isotype Control

Reference: HY-P99003
€0.00 (tax incl.)
Human IgG4 kappa, Isotype Control, a human monoclonal antibody, is an isotype control for human IgG4κ antibody.
Vesencumab Vesencumab

Vesencumab

Reference: HY-P99386
€0.00 (tax incl.)
Vesencumab (MNRP-1685A) is IG1 antibody against neuropilin-1 (NRP-1). Vesencumab binds to NRP-1 and prevents the subsequent coupling of NRP-1 to VEGFR-2. Vesencumab has anti-angiogenic and anti-neoplastic activities....
Burosumab Burosumab

Burosumab

Reference: HY-P9939
€0.00 (tax incl.)
Burosumab is a human fibroblast growth factor 23 (FGF23) neutralizing antibody that can be used for the research of X-linked hypophosphatemia (XLH) and tumor-induced osteomalacia.
Citatuzumab bogatox Citatuzumab bogatox

Citatuzumab bogatox

Reference: HY-P99282
€0.00 (tax incl.)
Citatuzumab bogatox (VB6-845) is recombinant immunotoxin that composed of Fab fragment of humanized antibody targeting EpCAM and a modified cytotoxin bouganin. Citatuzumab bogatox binds to and selectively induces...
Utomilumab Utomilumab

Utomilumab

Reference: HY-P99056
€0.00 (tax incl.)
Utomilumab (PF 05082566) is a fully human IgG2 mAb agonist of the T-cell costimulatory receptor 4-1BB/CD137. Utomilumab can be used for the research of relapsed/refractory follicular lymphoma (FL) and other CD20+...
Emactuzumab Emactuzumab

Emactuzumab

Reference: HY-P99245
€0.00 (tax incl.)
Emactuzumab(RG 7155) is a specific monoclonal antibody that inhibits colonystimulating factor 1 receptor (CSF1R) activation. Emactuzumab has high affinity for CSF-1R with Ki value of 0.2 nM to blocks CSF-1R...
Sacituzumab Sacituzumab

Sacituzumab

Reference: HY-P99045
€0.00 (tax incl.)
Sacituzumab is a humanized IgG1 monoclonal antibody for anti-trophoblast cell-surface antigen 2 (anti-Trop-2). Sacituzumab has the potential for metastatic triple-negative breast cancer research.
Abagovomab Abagovomab

Abagovomab

Reference: HY-P99276
€0.00 (tax incl.)
Abagovomab (Anti-Human CA-125 Recombinant Antibody) is a murine monoclonal anti-idiotypic antibody, against the tumor-associated antigen, CA-125. Abagovomab is generated by a mouse hybridoma, can imitate the human...
Nirsevimab Nirsevimab

Nirsevimab

Reference: HY-P99756
€0.00 (tax incl.)
Nirsevimab (MEDI8897) is a recombinant human respiratory syncytial virus (RSV) monoclonal antibody with modified Fc region, which can prolong its half-life. Nirsevimab has an affinity for RSV-B with an Kd value of 1.5...
Tildrakizumab Tildrakizumab

Tildrakizumab

Reference: HY-P99256
€0.00 (tax incl.)
Tildrakizumab (SCH 900222) is a humanized anti-IL-23 (p19 subunit) monoclonal antibody. IL-23 is a critical cytokine to maintain the Th17 cell phenotype. Tildrakizumab has high-affinity for single-chain IL-23 (Kd: 136...
Eptinezumab Eptinezumab

Eptinezumab

Reference: HY-P99017
€0.00 (tax incl.)
Eptinezumab is a human monoclonal antibody. Eptinezumab binds to calcitonin gene-related peptide (CGRP) and blocks its binding to the receptor. Eptinezumab can be used for the prevention of migraine in adults.
Teplizumab Teplizumab

Teplizumab

Reference: HY-P99222
€0.00 (tax incl.)
Teplizumab (MGA-031) is a Fc receptor non-binding anti-human CD3 monoclonal antibody. Teplizumab reduces the loss of beta-cell function. Teplizumab can be used in the research of type 1 diabetes.
Farletuzumab Farletuzumab

Farletuzumab

Reference: HY-P99153
€0.00 (tax incl.)
Farletuzumab (MORAb-003) is a potent folate receptor-alpha (FRα) inhibitor. Farletuzumab is a humanized monoclonal antibody with high affinity for FRα. Farletuzumab possesses growth-inhibitory functions on cells...
Oxelumab Oxelumab

Oxelumab

Reference: HY-P99408
€0.00 (tax incl.)
Oxelumab (R 4930) is a human monoclonal antibody against the OX40 ligand (OX40L). Oxelumab can be used for the research of asthma.
Balugrastim Balugrastim

Balugrastim

Reference: HY-P99458
€0.00 (tax incl.)
Balugrastim (CG 10639) is a novel long-acting recombinant granulocyte colony-stimulating factor (G-CSF) obtained by means of a genetic fusion between recombinant human serum albumin and granulocyte colony-stimulating...
Ociperlimab Ociperlimab

Ociperlimab

Reference: HY-P99763
€0.00 (tax incl.)
Ociperlimab is a humanized IgG1 anti-TIGIT antibody. Ociperlimab binds to the extracellular domain of human TIGIT with high affinity (KD = 0.135 nM). Ociperlimab blocks the interaction between TIGIT and its ligands...
Imvotamab Imvotamab

Imvotamab

Reference: HY-P99660
€0.00 (tax incl.)
Imvotamab (IGM-2323) is a CD20xCD3 bispecific IGM antibody with dual action mechanism. Imvotamab is used to induce physiological T cell activation to prevent over-stimulation and subsequent down-regulation of immune...
Efmarodocokin alfa Efmarodocokin alfa

Efmarodocokin alfa

Reference: HY-P99919
€0.00 (tax incl.)
Efmarodocokin alfa is a fusion protein of human IL-22 and the IgG4 crystallizable fragment. Efmarodocokin alfa activates IL-22 signaling. Efmarodocokin alfa can be used for the research of severe COVID-19 pneumonia.
CTX-2026 CTX-2026

CTX-2026

Reference: HY-P99179
€0.00 (tax incl.)
CTX-2026 is a fully human antibody that binds to CD277. CTX-2026 shows an anti-tumor effect on ovarian tumor models. CTX-2026 can be used for the research of cancer.
Tibulizumab Tibulizumab

Tibulizumab

Reference: HY-P99563
€0.00 (tax incl.)
Tibulizumab (LY 3090106) is a tetravalent bispecific monoclonal antibody targeting B-cell activating factor (BAFF) and IL-17A with Kd values of 60 pM and 14 pM, respectively. Tibulizumab can be used for autoimmune...
Suvratoxumab Suvratoxumab

Suvratoxumab

Reference: HY-P99583
€0.00 (tax incl.)
Suvratoxumab (MEDI4893) is a long-acting, high-affinity humanized anti-α-toxin monoclonal antibody (IgG1κ type). Suvratoxumab potently neutralizes α-toxin, a key S. aureus virulence factor. Suvratoxumab improves...
Spesolimab Spesolimab

Spesolimab

Reference: HY-P99396
€0.00 (tax incl.)
Spesolimab (BI 655130) is an anti-IL-36R antibody. IL-36 involves in immune system, as Spesolimab can be used for palmoplantar pustulosis (PPP) research. Spesolimab is associated with the reduction of biomarkers...
Pimivalimab Pimivalimab

Pimivalimab

Reference: HY-P99887
€0.00 (tax incl.)
Pimivalimab (JTX-4014) is a PD-1 inhibitor. Pimivalimab can be used for the research of solid tumor.
Valziflocept Valziflocept

Valziflocept

Reference: HY-P99529
€0.00 (tax incl.)
Valziflocept (BAX1810; TAK-752) is a recombinant soluble human FcγRIIb receptor that targets Fc and FcγR. FcγRs bind and neutralize pathogenic IgG, thus forming a "decoy" or "scavenger" receptor that can reduce the...
Berlimatoxumab Berlimatoxumab

Berlimatoxumab

Reference: HY-P99472
€0.00 (tax incl.)
Berlimatoxumab (ASN-2) is an antibody. Berlimatoxumab can be used for experiment research.
Vedolizumab Vedolizumab

Vedolizumab

Reference: HY-P9911
€0.00 (tax incl.)
Vedolizumab is a humanized IgG1 monoclonal antibody that targets the α4β7 integrin for the treatment of ulcerative colitis and Crohn's disease.
Tilvestamab Tilvestamab

Tilvestamab

Reference: HY-P99161
€0.00 (tax incl.)
Tilvestamab (BGB149) is a humanized anti-AXL antibody that blocks AXL-mediated cell signaling. Tilvestamab significantly inhibits Gas6-induced AXL activation in 786-0-Luc RCC cells and inhibits downstream AKT...
Albinterferon alfa-2B Albinterferon alfa-2B

Albinterferon alfa-2B

Reference: HY-P99427
€0.00 (tax incl.)
Albinterferon alfa-2B (alb-IFN) is a recombinant protein consisting of interferon alfa-2b genetically fused to human albumin. Albinterferon alfa-2B can be used for the research of chronic hepatitis C.
Stamulumab Stamulumab

Stamulumab

Reference: HY-P99588
€0.00 (tax incl.)
Stamulumab (MYO-029) is a recombinant human IgG1λ antibody that binds to myostatin and neutralizes its activity by preventing binding to its endogenous high-affinity receptor ActRIIB. Stamulumab leads to muscle fiber...
Elotuzumab Elotuzumab

Elotuzumab

Reference: HY-P9965
€0.00 (tax incl.)
Elotuzumab is a monoclonal antibody directed against the SLAMF7 receptor. Elotuzumab has no significant antimyeloma activity when given as a single agent with relapsed or refractory multiple myeloma (RRMM). Elotuzumab...
Sampeginterferon beta-1a Sampeginterferon beta-1a

Sampeginterferon beta-1a

Reference: HY-P99897
€0.00 (tax incl.)
Sampeginterferon beta-1a (BCD-054) is a pegylated IFNβ-1a. Sampeginterferon beta-1a can be used for research against remitting multiple sclerosis.
Pulocimab Pulocimab

Pulocimab

Reference: HY-P99808
€0.00 (tax incl.)
Pulocimab is an anti-VEGFR2 monoclonal antibody (mAb). Pulocimab can be used for the research of cancers.
Anti-Mouse CD11a Antibody Anti-Mouse CD11a Antibody

Anti-Mouse CD11a Antibody

Reference: HY-P99120
€0.00 (tax incl.)
Anti-Mouse CD11a Antibody is an anti-mouse CD11a IgG2b antibody inhibitor derived from the host Rat.
Etanercept Etanercept

Etanercept

Reference: HY-108847
€0.00 (tax incl.)
Etanercept, a dimeric fusion protein that binds TNF, acts as a TNF inhibitor. Etanercept competitively inhibits the binding of both TNF-α and TNF-β to cell surface TNF receptors, rendering TNF biologically inactive....
Talacotuzumab Talacotuzumab

Talacotuzumab

Reference: HY-P99395
€0.00 (tax incl.)
Talacotuzumab (JNJ 56022473; CSL 362) is an IgG1-type fully humanized, CD123-neutralizing monoclonal antibody containing a modified Fc structure. Talacotuzumab has KDs of 0.43 nM, 188 nM, 46 nM, 16.8 nM for CD123,...
Relfovetmab Relfovetmab

Relfovetmab

Reference: HY-P99825
€0.00 (tax incl.)
Relfovetmab is an anti-NGF monoclonal antibody (mAb).

Menu

Settings

Please sign in first.

Sign in